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Summary
Cardiac troponins, cardiac troponin T (cTnT) and cardiac troponin I (cTnI), are the biochemical cornerstones in the diagnosis of acute myocardial infarction without characteristic changes on the electrocardiogram (ECG). The recent introduction of the high-sensitivity cardiac troponin assays was at the basis of the increasingly accurate and rapid clinical decision making in patients with acute chest pain. Nevertheless, the increased sensitivity of the recent assays has not only expedited diagnosis of acute myocardial infarction, but also resulted in the detection of, previously undetectable, low cardiac troponin concentrations in subjects without acute myocardial infarction. The aim of this thesis is to increase our understanding of basal cardiac troponin levels in non-acute conditions, their impact on the diagnostics of acute myocardial infarction, and how these aspects can be used to improve the interpretation of cardiac troponins levels.
Chapter 1 provides a general introduction on cardiac troponins and the diagnosis of acute myocardial infarction. Furthermore, it describes the prevalence and prognostic value of persistently elevated cardiac troponin concentrations.
Chapter 2 illustrates the impact of chronically elevated cardiac troponin concentrations with a case. This case highlights four aspects that are discussed in this thesis (discussed in the following chapters): First, the variation in cardiac troponin concentrations over the day (chapters 3 and 4) . Second, the effect of impaired renal function on cardiac troponin levels (chapters 5 and 6). Third, the differences between cTnT and cTnI (chapters 7 and 8). Fourth, persistently elevated basal cardiac troponin concentrations and their clinical significance (chapters 9, 10 and 11).
Since increased cardiac troponin concentrations are not specific for the presence of an acute myocardial infarction, serial measurement of cardiac troponins is of profound importance in diagnostics. An important assumption for the interpretation of these serial cardiac troponin concentrations is the random variation of concentrations in clinically stable conditions. In chapters 3 and 4, we demonstrate that this assumption holds true for cTnI, but not for cTnT.
Specifically, in chapter 3, which contains the results of a biological variation study with hourly sampling during day and night in 24 patients without chronic kidney disease, we show an Summary 209 omnipresent diurnal rhythm in cTnT. This rhythm is characterized by gradually decreasing concentrations during the day and increasing concentrations of cTnT during night-time. Since the diurnal pattern in cTnT concentrations may cause increases or decreases in serial measurements to be more likely in certain timeframes, we additionally evaluated the effect of time on the diagnostic accuracy in an international multicenter diagnostic trial (2782 patients with acute chest pain). This evaluation shows a very high and time-frame independent diagnostic accuracy of cTnT for the diagnosis of acute myocardial infarction.
Nevertheless, in early presenters (≤ 3h after the onset of chest pain) the effect of the timeframe seems to be more pronounced and leads to a borderline significant decrease in diagnostic accuracy for cTnT concentrations at one hour after presentation and for the combination of cTnT concentration at presentation combined with the absolute change within the first hour. Therefore, the diurnal rhythm may provide an explanation in cases where the clinical assessment is discordant with the biochemical kinetics. In addition, this chapter shows random variation in cTnI levels over the day without an effect on the diagnostic accuracy of cTnI. Moreover, chapter 4 focuses on the variation in cTnI levels during day and night. In addition to the population described in chapter 3, we included 20 subjects with chronic kidney disease. Their baseline cTnI levels were slightly higher and accompanied by a significant lower analytical coefficient of variation compared to the subjects without chronic kidney disease. Nevertheless, we observed a similar random variation in cTnI levels over the day in both groups.
Persistently elevated cardiac troponin concentrations are highly prevalent among subjects with impaired renal function. A better understanding and interpretation of these elevations, requires more insight in the underlying mechanism: Is it the heart, by increased release, or the kidneys, by decreased renal elimination? Chapters 5 and 6 consider the role of the kidneys in the terminal elimination of cTnT from the circulation. Chapter 5 builds upon the previous chapters and employs the diurnal oscillation pattern of cTnT as a model to assess the contribution of impaired renal elimination to persistently elevated cTnT levels in in patients with chronic kidney disease. Mathematically modeling shows that impaired elimination of cTnT should lead to a faded circadian rhythm characterized by a substantial Cardiac Troponins: State of the (He)Art 210 decrease in amplitude. Nevertheless, the pattern and the amplitude of the circadian rhythm in cTnT is similar in subjects with or without chronic kidney disease. These observations strongly suggest that other factors, such as increased release of cardiac troponins from the heart due to (subclinical) myocardial injury, are responsible for persistently elevated cardiac troponin levels in subjects with decreased renal function. Whereas the previous chapter focuses on the elimination of cTnT in a chronic setting, chapter 6 examines the elimination of cTnT in patients suffering from acute myocardial infarction. We are the first to develop and validate a targeted mass spectrometry assay for the detection of cTnT (fragments) in urine. Subsequently, we show the presence of cTnT fragments in a subset of patients.
Nevertheless, whether the presence of cTnT in urine reflects a physiological or rather a pathophysiological process needs to be elucidated.
cTnT and cTnI are both proteins from the same complex inside the cardiomyocytes and are equally recommended for the diagnosis of acute myocardial infarction. Although there are some clear differences between both cardiac troponins, which are further highlighted in chapters 7 and 8. In chapter 7, we show a substantial variation in cTnT concentrations in both serum and plasma of different individuals after the addition of a standardized amount of cardiac troponin. This evident variation is not present for other cardiac biomarkers (cTnI, creatine kinase MB isoenzyme and myoglobine) and disappears when the experiment is replicated in deproteinated serum. These findings indicate the presence of one or more factors that have specific interaction with cTnT and not with cTnI. Additional studies have to elucidate whether this effect can also be found in vivo and what its exact clinical implications are. Chapter 8 examines the clinical impact of the use of the different cardiac troponins for the diagnosis of acute myocardial infarction and evaluates whether combining them might overcome individual limitations. When applying the current 0-hour/1-hour algorithm for cTnT or for cTnI in an international multicenter center diagnostic trial (2225 patients with acute chest pain), the agreement on the early diagnosis of acute myocardial infarction is moderate and the rule-out of patients without an acute myocardial infarction at presentation is limited. The combination of cTnT and cTnI for the rule-out of acute myocardial infarction leads to a significant increase in the number of safe rule-outs after a single blood draw. These Summary 211 results are supported by the validation of combination strategies in an external cohort (2539 patients). Nevertheless, some limitations of this strategies merit attention: First, the 3-to-6-fold increase in rule-outs at presentation due to combining cTnT and cTnI seems to lead to a very small, but inevitable increase in the absolute number of false-negative results. Second, the clinical implementation of this dual-marker approach would currently be associated with substantial logistic obstacles.
The final part of this thesis reflects on persistently elevated cardiac troponin concentrations that are common in various subpopulations and associated with an unfavorable prognosis.
Chapters 9 and 10 explore the effects of exercise training, a preventive lifestyle intervention, on the course of basal cardiac troponin levels. In chapter 9, we analyze the effects of a 24-week resistance-type exercise training program on the cTnT levels of (pre)frail elderly. There is no significant difference in the course of cTnT levels between the intervention (25 subjects) and the control group (27 subjects). A limitation of this study might be the limited (absolute) training load due to the frailty of the subjects. Furthermore, the effect on cTnI concentrations is unclear. To overcome these limitations, chapter 10 presents two additional exercise training studies (including 13 and 39 subjects) and an additional analysis of cardiac cTnI in the previous study. Despite the beneficial changes in metabolic profile and physical performance, there is also no effect on circulating cardiac troponins levels in these studies.
To quantify the relationship between basal cardiac troponin levels and prognosis in the general population, we perform a meta-analysis in Chapter 11. This meta-analysis with data on 65019 participants from 11 cohort studies shows a robust association of basal cardiac troponin levels with all-cause and cardiovascular mortality during follow-up in the general population.
Lastly, chapter 12, contains a general discussion of the work presented in this thesis and provides directions for future research. Daarnaast laat deze studie in het midden of er mogelijke effecten op cTnI zijn. In hoofdstuk 10 hebben we, rekening houdend met de beperkingen van de vorige studie, de studie uit hoofdstuk 9 verder uitgebreid. Hiertoe hebben we twee extra trainingsstudies toegevoegd (met respectievelijk 13 en 39 deelnemers) en hebben we in alle studies ook cTnI bekeken.
Ondanks duidelijke verbeteringen op metabole en fysieke parameters, zagen we ook in deze studie geen effect op cardiale troponineconcentraties. Ten slotte, hebben we in hoofdstuk op vroegtijdige overlijden van mensen in de algemene populatie gekwantificeerd. De uitgevoerde meta-analyse bevat data van 11 cohort studies (in totaal 65019 deelnemers) en laat zien dat verhoogde basale cardiale troponineconcentraties samenhangen met een grotere de kans op vroegtijdig overlijden.
Tot slot bevat hoofdstuk 12 een algemene discussie over het in dit proefschrift beschreven werk en worden suggesties voor vervolgonderzoek aangedragen.
